A Polyherbal Formulation for a Wide Spectrum of Reproductive Tract and Sexually Transmitted Infections
Sexually transmitted infections (STI) are on an increase worldwide. According to WHO 1, 333 million new cases of STIs occur globally every year excluding HIV, and HIV is assuming pandemic proportions in many countries. Besides this, reproductive tract infections (RTIs) caused by aerobic, anaerobic bacteria, protozoa, yeast (Candida) etc, manifested in the syndrome of abnormal vaginal discharge (AVD) are widespread. Its prevalence is around 30% in women visiting public hospitals in cities in India2 and is over 50% in rural areas3. One billion events of bacterial vaginosis are believed to occur globally in a year4. Although antibiotics and oral ± local vaginal use therapies are available for most of the pathogens, their rational use requires diagnosis of the causative organism, but facilities for their diagnosis are not available universally, specially in economically developing countries. The objective of our work was to develop a vaginal formulation, whose use be totally under the control of the woman, and which could protect her as much as possible from sexually transmitted infections. In addition, the formulation as a single locally applied “drug” was aimed to act across the spectrum of micro-organisms responsible for the syndrome of AVD. This charter demanded not one but a combination of ingredients as there is no single compound known which acts on all micro-organisms responsible for AVD. Furthermore, as a frequently used preparation, it has to be safe and free from causing inflammation or mucosal damage, which the presently marketed vaginal suppositories, creams, sponges do. These preparations are based on powerful surfactants such as Nonoxynol-9 (N-9), benzalkonium chloride etc.
KeywordsSexually Transmit Infection Bacterial Vaginosis Chlamydia Trachomatis Benzalkonium Chloride Azadirachta Indica
Unable to display preview. Download preview PDF.
- 1.World Health Organization: Report on Fighting Disease Fostering Development, Geneva, (1996).Google Scholar
- 2.RA Bhujwala, K Buckshee, Sriniwas. Gardnerella vaginitis and associated aerobic bacterials in nonspecific vaginitis. Ind J Med Res, 81; 251–256, (1985).Google Scholar
- 4.M Morris, A Nicoll, I Simms, Jeffrey M Spieler. Bacteial vaginosis: a public health review. British J Ob & Gy; 108:439–450, (2001).Google Scholar
- 6.AR Rao, SSU Kumar, TB Paramsivan, S Kamalakshi, AR Parashuraman, M Shantha. Study of antiviral activity of tender leaves of margosa tree (Melia azadirachta) on vaccinia and variola virus, a preliminary report. Ind J Med Res 57; 495–502, (1969).Google Scholar
- 7.N Pant, HS Garg, KP Madhusudanan, DS Bhakuni. Sulfurous compounds from Azadirachta indica leaves. Fitoterapia, 57; 302–304, (1986).Google Scholar
- 8.Ravi Dhar, Zhang Kuniyan, GP Talwar, S Garg, N Kumar. Inhibition of the growth and development of asexual and sexual stages of the drug sensitive and resistant strains of the human malarial parasite plasmodium falciparum by Neem (Azadirachta indica) fractions. J Ethnopharmacology 61:31–39, (1998).CrossRefGoogle Scholar
- 9.R Dhar, H Dawar, S Garg, SF Basir, GP Talwar. Effect of volatiles from neem and other natural products on gonotrophic cycle and oviposition of Anopheles stephensi and An culcifacies. J Med Entomol. 33:195–201, (1996).Google Scholar
- 10.H Rembold. Azadirachtin—a botanical growth inhibitor and its relation to Biosemiotics In Recent Trends in Life Sciences. (Indian National Science Academy, New Delhi) pp. 471, (1994).Google Scholar
- 11.National Research Council. Neem—A tree for solving Global Problems. Washington DC: National Academy Press. (1992).Google Scholar
- 15.P Rahuvanshi, R Bagga, D Malhotra, S Gopalan, GP Talwar. Spermicidal and contraceptive properties of Praneem polyherbal pesary. Ind J med Res 113:135–141, (2001).Google Scholar
- 16.GP Talwar, P Raghuvanshi, R Mishra, U Bannerjee, A Rattan, KJ Whaley, L Zeitlin, SL Achilles, FB Sinoussi, A David, GF Doncel. Polyherbal formulations with wide spectrum antimicrobial activity against reproductive tract infections and sexually transmitted pathogens. Am J Reprod Immunol 43:144–158 L (2000)PubMedCrossRefGoogle Scholar
- 17.OA Ladipo. South to South experience with polyherbal cream in the treatment of vaginal infections. In Barrier contraceptives Eds. Christine K Mauck, Milton Cardero, Henry L Gabelnick, Jeffrey M Spieler, Roberto Rivera. New York. Wiley-Liss pp. 277–282, (1994).Google Scholar